Kindred Biosciences Inc (KIN)

[mick]

$KIN Kindred Biosciences (NASDAQ:KIN) Frequently Asked Questions
HOW HAS KINDRED BIOSCIENCES' STOCK BEEN IMPACTED BY COVID-19 (CORONAVIRUS)?

https://www.marketbeat.com/stocks/NASDAQ/KIN/?RegistrationCode=SocialMedia-StockTwits&utm_source=GeneralSocialMedia&utm_medium=Social&utm_campaign=SocialMedia

Kindred Biosciences' stock was trading at $8.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, KIN shares have decreased by 58.6% and is now trading at $3.35.
View which stocks have been most impacted by Coronavirus.

DO WALL STREET ANALYSTS RECOMMEND INVESTORS BUY SHARES OF KINDRED BIOSCIENCES?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kindred Biosciences in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Kindred Biosciences.

WHEN IS KINDRED BIOSCIENCES' NEXT EARNINGS DATE?
Kindred Biosciences is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020.
View our earnings forecast for Kindred Biosciences.

HOW CAN I LISTEN TO KINDRED BIOSCIENCES' EARNINGS CALL?
Kindred Biosciences will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.